Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Terry Rosen
South San Francisco, California,United States
Find Terry Rosen's Email
Find Terry Rosen's PhoneWho Is Terry Rosen?
Terry Rosen, Ph.D., is a distinguished scientist and seasoned executive in the biopharmaceutical industry, currently serving as the co-founder and Chief Executive Officer of Arcus Biosciences. With a career spanning over three decades, he has established a formidable reputation for his expertise in drug discovery and development, particularly in the field of oncology. Prior to Arcus, Dr. Rosen co-founded and led Flexus Biosciences as CEO, which was acquired by Bristol-Myers Squibb for $1.25 billion in 2015. His extensive experience includes senior leadership roles at Tularik (acquired by Amgen), Amgen, and Pfizer, where he was instrumental in the discovery and development of several approved medicines. He holds a Ph.D. in medicinal chemistry from the University of California, Berkeley.
How Did Terry Rosen's Career Path Shape Their Journey?
Terry Rosen's work history includes a series of influential roles in various companies. Here is a detailed list of his professional journey:
What Are Terry Rosen's Key Achievements?
Co-Founder and CEO of Arcus Biosciences
Co-founded Arcus Biosciences in 2015 to develop innovative combination therapies for cancer. As CEO, he has guided the company through significant growth, advancing its pipeline of clinical-stage immuno-oncology candidates and securing a major strategic collaboration with Gilead Sciences.
Successful Acquisition of Flexus Biosciences
Co-founded and served as CEO of Flexus Biosciences, a company focused on small molecule cancer immunotherapies. He led the company to a highly successful acquisition by Bristol-Myers Squibb for $1.25 billion just two years after its inception, showcasing his ability to create and realize significant value.
Key Inventor of SUTENT® (sunitinib)
During his tenure at Pfizer (formerly Sugen), Dr. Rosen was a co-inventor of SUTENT® (sunitinib malate), a multi-kinase inhibitor that became a blockbuster drug for treating advanced renal cell carcinoma and other cancers, demonstrating his direct impact on creating life-saving therapies.
Prolific Inventor and Scientist
Holds a significant number of issued U.S. patents and has contributed to numerous scientific publications. His work has directly led to the discovery and development of multiple approved drugs and clinical candidates throughout his career at Pfizer, Amgen, and his own ventures.
What's Terry Rosen's Educational Background?
Ph.D. in Chemistry
University of California, Berkeley - Year 1981
B.S. in Chemistry
University of Michigan - Year 1977
Buying Intent Signals for Terry Rosen
Highperformr Signals uncover buying intent and give you clear insights to target the right people at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Company Overview
Arcus BiosciencesArcus Biosciences is a clinical-stage biopharmaceutical company dedicated to developing innovative cancer therapies. The company focuses on creating first-in-class and best-in-class combination treatments aimed at activating the immune system to fight cancer, with a robust pipeline of molecules targeting critical tumor-intrinsic and immunological pathways.
Highperformr's free tools for company research
Find contact info
Get verified emails, phone numbers, and LinkedIn profile details
Find similar contacts
Discover contacts with similar roles, seniority, or companies
Perform deep contact research
Uncover insights like skills, work history, social links, and more
Discover, research and enrich contacts with Highperformr — Smarter, Faster
Explore contacts in-depth — from verified emails and phone numbers to LinkedIn activity, job changes, and more — all in one powerful view.
Highperformr AI helps you surface the right people and enrich your CRM with live, accurate contact insights so your teams can connect faster and close smarter.
- Track signals like job change, promotion, and LinkedIn activity
- Enrich contacts with verified email, phone, and social data instantly
- Automate enrichment and updates with powerful workflows
- Sync enriched contact info directly into your CRM and tools
Thousands of contacts — including decision-makers, influencers, and ICP matches — are just a search away.
Thousands of companies, including, are just a search away.